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variable VentilatorySupport ICU LOS (daya) Suwlval(4-year)l
n (%) (daya)
~ 2’0 ,70
(daya)
Aga (yrs) <70 ~70 <70 270 <70 -
COPD 25(15) 17 (35) 6* 10* 15 24 .91 56
No-COPD 38 (8) 19 (15) 4 5 11 16 92 65.–,
Smoker 27(12) i ~23j 5 11 12 28 67 60
Non-Smoker 34 (9) 30 (19) 4 6 12 16 91 80
FEVl (L)
<2.0 9 (13) 6 (30) 5 7 14* 17 76* 24”
2.0-3.0 24 (12) 9 (12) 5 7 12 16 67 80
>3.0 6 (3) 2 (lo) 4 5 10 15 94 93
*p< 0.05 (unlvartate/muhivarlateIog-ranktesta), t Kaplan-Meier method
Preoperative FEVi significantly affected LOS in the hoepital only in the
patienta <70 years of age (p= 0.0001). Delayed extubation (> 4S hre) had
resulted in prolongad LOS in the ICU and in the hospital for patients <70
years (p= 0.0001, p = O. 0001, respectively) and patients 270 yeare (p =
0.GIX31, p = 0.0001, reapacflvely). The 4-year survival after CABG for young
and old patienta was significantly influenced by the level of preoperative FEVI
(p= 0.0004p=0.0282irespectively). We conclude that preoperative FEVI
ie a significant predictor of 4-year survival in the young and agad individual
undergoing CABG.
m952126 IsSerotoninsn UnexpectedCaueeofArterialGraftSpaem?DynamicveStaticEvaluationof
PorcineInternalThoracicArteriee
W.D. Montgomery, J.L. Ballen, C.J. Riordan, A. Ali, W.P.Santamore,
P.A.Spance. UniversifyofLouisville,Louisville,KK USA
We mmparad the effect of serotonin (5HT) and norepinephrine (NE) on
internal thoracic artery (ITA) spasm in both a dynamic pertuaion system and
atatic arterial ring preparation. Porcine ITAs (N = 12, 2.0-2.5 mm) were
mounted on a computer controlled perfuaion apparatua. Inflow pressure
(SOmmHg) and outflow resistance were adjusted to simulate high (80-100
mUmin) and normal(15-20 mUmin) graft flow. Preasure and flows were
examined at baseline and after adding NE and 5HT. In addition, rings (N =
15,3.0 mm) were mounted on ateneion gauge and contraction in response
to NE and 5HT were obtained.
Flow State DistalPreeeure(mmHg) Flow (m!Jmin) ED50 (-logM)
13asalina Final Baseline Final
NE TrsatedlT4e (N.5, I(Te to 10_5 M)
NORM 7S.O& 0.6 77.6* 0.5 15.6+ 1.9 15.3+ 1.7 NoResfnxwe
HIGH 83.2+ 2.2 27.0+ l.e+ 99.4+ 5.0 45.44=2.7” 8.04* 0.58
5HTTreatad\7Ae (N= 7, 10_g tO 10_5 M)
NORM 77.2+ 2.2 57.8 & 7.5* 19.1 + 7.9 10.9 +0.6” 6.35+ 0.55
HIGH 60.3+ 3.8 21.e+ 2.2* 76.7k4.4 26.7* 3.6* 6.59+ 0.34
Mean + SE, *p c 0.05 compared to Baseline
Under high graft flow conditions, ‘NE and 5HT caused significant de-
creaees in flow and distal pressure with 5HT the most potent (86.IYo J in
flow). Under nonnalgrafl flow conditions, NE caused nodecrease in flow or
distal pressure whereas 5HTcaussd asignific$nt decrease inflow (42.9%$)
and distal preaeure. Static r!ngs treated with NE and 5HT 9ave similar do$e
response curvea with no significant differences in EDetI(NE: 6.71 k 0.1 va
5HT: 6.92 l 0.1). These reaults suggeeta an interaction between flow and
5HT which may augment its capacity as a vaaoconstrictor. Graft flow may
bean important but overlooked element in the generation of spaam induced
by endogenous vasoconatrictor aubatances. The clinical importance of 5HT
potency may have previously been undereatimatad.
952-127 EssentislImprovementto a Working,Isolated
RatHeartModelWithHemodvnamicendNMR
SpectroscopicMonitoring -
R.J.F. Houston, C.J.A.M. Zeebregts, S.H. Skotnicki, A. Heerachap,
F.W.A.Verheugt, B. Oeseburg. UniveraityofMjrnegen,NL-6500IYB
N~megen,TheNetherlands
To the cardiac eurgeon, effective cardioprotaction means recovery of heart
function after ischemia, and an experimental model to test cardioprotective
tachniquee should offer some meane of predicting damage. Loasofphospho-
craatine (PCr) is a very earfy indicator of myocerdial metabolic compromise;
we therefore developed an ejecting rat heart model in which the left atrium
and aorta are cannulatad, the parfusate is a suspension of bovine erythro-
cytes in artificial plasma to ensure adequate oxygen and metabolizesupply,
and in contrast to a Lengendorlf model, the heart performs real work inside
the bore of an NMR spectrometer (typically55 mL.min-f aorticoutput against
13 kPa: see diagram).
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A new phosphorus NMR spectrum can be obtained every five minutes,
giving on-line, nondestructive measurement of high-energy and inorganic
phosphates and intracellular PH.During pilot experiments, the hearts hung in
air at 3~C and typiCSllyrecovered 907. of left VentI’iCUlaroutput after 20 min
ischemia. However,we have now introduced a miniature temperature sensor
into the right ventricle, and with the heart immersed in a thermostatically
controlled bath, and a heat exchanger in the Lengendorlf pertusion line to
maintain real normothermia (38QC),thia degree of damage occurs after only
10 rein, at which time PCr reachea a very low level (<25% control); in air at
3X with relative humidity less than 100”A, rapid cooling occurs. Immersion
of the heart in erythrocyta-free solution aleo depresaes functional output,
while immersion in the etythrocyte suspension has no effect on work output.
A tightly-controlled, repeatable model such as this is essential for basic
research into cardioprotaction.
1952-128]Bl*ingWithCoronavAtieyBypasSurge~
(CABG)in PatientaTreatedwitha Platelet
GlycoproteinIIb/fllaInhibitor
B.E. Tardiff, J.E. Tcheng, S. Peck, A.M. Linmff, R.A. Harrtngton, R.M. Califf,
E.J. Topol, for the IMPACT-II Investigators. DukeUnivetaifyDurham,NC,
USA
There is mncem that the use of llb/lIla inhibitore for angioplasty (PTCA)
or unstable angina may be associated with increased bleeding if CABG is
later required. We examined perioperative bleeding and blood product use
in patients undergoing in.hospital CABG in the IMPACT II trial (evaluating
Integrilin in PTCA). Hematological change variables (pre-bypass value minus
in-hospital nadir), blood product use, bleeding index (Bl, AHcf/3 + # unite
transfuead), and clinical outcomes at 30 days are shown. Values are median
(25’h,75’h percentiles) or n (%).
Integrilinhi dose Integrilin10daee ;Acebo
(n= 37) (n= 44) (n= 53)
AHgb 6(4, 7) 5(4, 6) 5(4, 7)
AHct 18(14,20) 16(11, 19) 17(13, 22)
AplateletSx 1000 60(21, 103) 69(-6, 113) 87(32, 129)
PRBC units 2(0,4) 2(0,4) 2(0.4)
FFPunita 0(0,2) 0(0,1) 0(0,0)
plateletunite 0(0, 2) 0(0,2) 0(0,1)
BI 9(6,10) 6(5,10) 7(6.10)
death (30 days) 2(5”/.) 1(2%) 4(6%)
Ml (30days) 1O(27”A) ll(25°A) 17(32”A)
In a multivarfable model (including clinical characteristics), treatment arm
waa not a significant pr&tictor of B1.
Conclusion:Use of Integrilin, a potent platelet inhibitor, to manage is-
chemic complications of PTCA does not seem to be associated with more
aevere bleeding with later CABG or more frequent tranafusiona. Xl-day out-
comes also appeared favorable in this small aample.
m952134 CompleteMyocardialRevascularieetionwithTrsnsmyocardialLaserasanAdjunctto CABG
withoutCardiopulmonaryBypass
N.”Trehan,R. Bapna, A. Mishra, Y. Mehta, V.M. Kohli, Y. Mishra, M. Mishra.
EscortsHeartinstituteAndResearchCentre,NewDe/hi,India
There isa large group of patients where conventional bypass grafting cannot
be adequately accomplished in all territories because of diffuae disease or
lack of distal targets. Many of theae patients are at high risk because of se-
vere systemic disease, aortic atherosclerosis, advanmd age etc. TMLR as
an adjunct to CABG offere a new approach whereby total myocsrdial revas-
cularieation can beachievad in these patients without the uss of CPB. TMLR
combined with CABG on beating heart without CPB hae been performed on
56 patients. Age ranged from 37-81 yeare (mean 56.17+ 10.36). The mean
LVEFwas44.59• 10.04. Nine patients had EF e 35~o. Mean numbarof ves-
sele bypaaaadwere 1.09. IMA was used in all cases. 4 patienta were in renal
